Copper(I) Chelators for Alzheimer's Disease

Area of Science:

• Neuroscience
• Chemistry
• Computational Chemistry

Background:

• Beta-amyloid peptide (Aβ) neurotoxicity in Alzheimer's disease is partly mediated by its copper complex (Aβ/Cu+).
• This complex reacts with oxygen to produce harmful superoxide, hydrogen peroxide, and hydroxyl radicals.

Purpose of the Study:

• To design novel compounds (L) capable of removing Cu+ from Aβ/Cu+.
• To ensure the resulting L/Cu+ complexes do not catalyze the reduction of oxygen or hydrogen peroxide.

Main Methods:

• Density functional calculations were employed to evaluate potential compounds.
• The study focused on pincer-type compounds featuring imidazole rings and sulfur or nitrogen atoms.

Main Results:

• Several pincer-type compounds demonstrated high affinity for Cu+.
• These compounds, when complexed with Cu+, exhibited low reduction potential, preventing further radical generation.
• The designed ligands effectively sequester copper from Aβ.

Conclusions:

• Pincer-type compounds with specific structural features can effectively chelate copper from Aβ.
• These compounds offer a potential therapeutic strategy to mitigate Alzheimer's disease-associated oxidative stress.